Literature DB >> 19216075

Synthesis and SAR of piperazinyl-N-phenylbenzamides as inhibitors of hepatitis C virus RNA replication in cell culture.

Immacolata Conte1, Claudio Giuliano, Caterina Ercolani, Frank Narjes, Uwe Koch, Michael Rowley, Sergio Altamura, Raffaele De Francesco, Petra Neddermann, Giovanni Migliaccio, Ian Stansfield.   

Abstract

The RNA replication machinery of HCV is a multi-subunit membrane-associated complex. NS5A has emerged as an active component of HCV replicase, possibly involved in regulation of viral replication and resistance to the antiviral effect of interferon. We report here substituted piperazinyl-N-(aryl)benzamides as potent inhibitors of HCV replication exerted via modulation of the dimerization of NS5A.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19216075     DOI: 10.1016/j.bmcl.2009.01.066

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

Review 1.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

2.  TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.

Authors:  D G Cordek; J T Bechtel; A T Maynard; W M Kazmierski; C E Cameron
Journal:  Drugs Future       Date:  2011-09       Impact factor: 0.148

Review 3.  HCV drug discovery aimed at viral eradication.

Authors:  R F Schinazi; L Bassit; C Gavegnano
Journal:  J Viral Hepat       Date:  2009-12-18       Impact factor: 3.728

4.  Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052.

Authors:  Robert A Fridell; Dike Qiu; Lourdes Valera; Chunfu Wang; Ronald E Rose; Min Gao
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

5.  Kinetic analyses reveal potent and early blockade of hepatitis C virus assembly by NS5A inhibitors.

Authors:  David R McGivern; Takahiro Masaki; Sara Williford; Paul Ingravallo; Zongdi Feng; Frederick Lahser; Ernest Asante-Appiah; Petra Neddermann; Raffaele De Francesco; Anita Y Howe; Stanley M Lemon
Journal:  Gastroenterology       Date:  2014-04-22       Impact factor: 22.682

6.  Metabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activity.

Authors:  Annalisa Bianco; Veronica Reghellin; Lorena Donnici; Simone Fenu; Reinaldo Alvarez; Chiara Baruffa; Francesco Peri; Massimiliano Pagani; Sergio Abrignani; Petra Neddermann; Raffaele De Francesco
Journal:  PLoS Pathog       Date:  2012-03-08       Impact factor: 6.823

7.  Identification of hepatitis C virus NS5A inhibitors.

Authors:  Julie A Lemm; Donald O'Boyle; Mengping Liu; Peter T Nower; Richard Colonno; Milind S Deshpande; Lawrence B Snyder; Scott W Martin; Denis R St Laurent; Michael H Serrano-Wu; Jeffrey L Romine; Nicholas A Meanwell; Min Gao
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

8.  NS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase IIIα complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranes.

Authors:  V Reghellin; L Donnici; S Fenu; V Berno; V Calabrese; M Pagani; S Abrignani; F Peri; R De Francesco; P Neddermann
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

Review 9.  Approaches to hepatitis C treatment and cure using NS5A inhibitors.

Authors:  James J Kohler; James H Nettles; Franck Amblard; Selwyn J Hurwitz; Leda Bassit; Richard A Stanton; Maryam Ehteshami; Raymond F Schinazi
Journal:  Infect Drug Resist       Date:  2014-03-05       Impact factor: 4.003

Review 10.  Regulatory Role of Phospholipids in Hepatitis C Virus Replication and Protein Function.

Authors:  Anna V Bulankina; Rebecca M Richter; Christoph Welsch
Journal:  Pathogens       Date:  2022-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.